BRCA1 and breast cancer: The women with the BRCA1 delexon20 mutation had a breast cancer diagnosed at the age of 31 at recruitment, and subsequently another at age 35 years, and had an unverified report of breast cancer in a paternal grandmother (age at diagnosis unknown).